Skip to main content

Intragastric Balloon for Overweight Patients.

Publication ,  Journal Article
Martins Fernandes, FA; Carvalho, GL; Lima, DL; Rao, P; Shadduck, PP; Montandon, ID; de Souza Barros, J; Rodrigues, ILV
Published in: JSLS
2016

BACKGROUND AND OBJECTIVES: Current treatments for overweight adults include reduced-calorie diet, exercise, behavior modification, and selective use of medications. Many achieve suboptimal results with these measures and progress to obesity. Whether the intragastric balloon (IGB), a reversible device approved for treatment of obesity, is a safe and effective option in overweight adults is less well studied. We conducted a study to prospectively analyze the safety and effectiveness of IGB in overweight adults, to compare the results to a simultaneously studied cohort of obese patients, and to share procedural tips for safe IGB placement and removal. METHODS: One hundred thirty-nine patients were evaluated in this prospective, nonrandomized study. Twenty-six overweight [body mass index (BMI), 26-30)] and 113 obese (BMI > 30) patients underwent outpatient, endoscopic IGB placement under intravenous sedation. The IGB was filled with a 550-900 mL (average, 640 mL) solution of saline, radiological contrast, and methylene blue, with an approximate final proportion of 65:2:1. The patients were followed up at 1-2 weeks and then monthly for 6 months. At 6 months, they underwent IGB removal via an esophageal overtube to optimize safety, and then they were observed for 6 more months. RESULTS: IGB time was 190 ± 36 d in the overweight patients and 192 ± 43 d in the obese patients. Symptoms of IGB intolerance included nausea and pain, which were transiently present in 50-95% of patients for several days, and necessitated early IGB removal in 6% of patients. There were no procedure-related complications and no IGB-related esophagitis, erosion, perforation, or obstruction. The percentage of excess weight loss (EWL%) was 96 ± 54% in the overweight group and 41 ± 26% in the obese group (P < 0.001). CONCLUSION: In overweight adults failing standard treatments, IGB placement for 6 months had an acceptable safety profile and excellent weight loss.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JSLS

DOI

EISSN

1938-3797

Publication Date

2016

Volume

20

Issue

1

Location

United States

Related Subject Headings

  • Weight Loss
  • Treatment Outcome
  • Surgery
  • Prospective Studies
  • Obesity, Morbid
  • Middle Aged
  • Male
  • Humans
  • Gastric Balloon
  • Follow-Up Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Martins Fernandes, F. A., Carvalho, G. L., Lima, D. L., Rao, P., Shadduck, P. P., Montandon, I. D., … Rodrigues, I. L. V. (2016). Intragastric Balloon for Overweight Patients. JSLS, 20(1). https://doi.org/10.4293/JSLS.2015.00107
Martins Fernandes, Flavio Augusto, Gustavo L. Carvalho, Diego L. Lima, Prashanth Rao, Phillip P. Shadduck, Isabelle D. Montandon, Juscielle de Souza Barros, and Ingrid Lais Vieira Rodrigues. “Intragastric Balloon for Overweight Patients.JSLS 20, no. 1 (2016). https://doi.org/10.4293/JSLS.2015.00107.
Martins Fernandes FA, Carvalho GL, Lima DL, Rao P, Shadduck PP, Montandon ID, et al. Intragastric Balloon for Overweight Patients. JSLS. 2016;20(1).
Martins Fernandes, Flavio Augusto, et al. “Intragastric Balloon for Overweight Patients.JSLS, vol. 20, no. 1, 2016. Pubmed, doi:10.4293/JSLS.2015.00107.
Martins Fernandes FA, Carvalho GL, Lima DL, Rao P, Shadduck PP, Montandon ID, de Souza Barros J, Rodrigues ILV. Intragastric Balloon for Overweight Patients. JSLS. 2016;20(1).

Published In

JSLS

DOI

EISSN

1938-3797

Publication Date

2016

Volume

20

Issue

1

Location

United States

Related Subject Headings

  • Weight Loss
  • Treatment Outcome
  • Surgery
  • Prospective Studies
  • Obesity, Morbid
  • Middle Aged
  • Male
  • Humans
  • Gastric Balloon
  • Follow-Up Studies